Deeper Understanding of COVID-19 Phenotypes Through Metabolomics: A Panel Discussion

How are researchers studying COVID-19 using metabolomics to get closer to the phenotype?

Since the rapid progression of COVID-19 (SARS-CoV-2), researchers across the globe have moved at a breathtaking pace to understand the progression of the disease in and develop effective treatments. Join us for a panel discussion with practitioners who’ve used metabolomics in their studies to understand COVID-19 better as they share findings from recently or soon to be published studies and their perspectives.

View this webinar to:

  • Hear about different research approaches and study design impacts
  • Explore how metabolomics can be integrated into multi-omics studies
How United Therapeutics leverages metabolomics to get closer to the phenotype increasing confidence in clinical trial decisions


Related Webinars